# Preformed Line Products Co: financial statements, quarterly

PLPC · Nasdaq · CIK 80035 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/plpc.md) · [Financials](/companies/plpc/financials.md) · [Filings](/companies/plpc/filings.md) · [Insiders](/companies/plpc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/plpc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [160](/filings/0001628280-24-044522.md) | [146 d](/filings/0000080035-26-000007.md) | [141](/filings/0001628280-25-021769.md) | [139](/filings/0000080035-25-000013.md) | [147](/filings/0000080035-25-000022.md) | [167 d](/filings/0000080035-26-000007.md) | [149](/filings/0000080035-26-000017.md) | [170](/filings/0000080035-26-000030.md) | [178](/filings/0000080035-25-000022.md) | [173 d](/filings/0000080035-26-000007.md) | [176](/filings/0000080035-26-000017.md) | [213](/filings/0000080035-26-000030.md) |
| Cost of revenue | $m | [106](/filings/0001628280-24-044522.md) | [97.5 d](/filings/0000080035-26-000007.md) | [96.8](/filings/0001628280-25-021769.md) | [94.4](/filings/0000080035-25-000013.md) | [101](/filings/0000080035-25-000022.md) | [111 d](/filings/0000080035-26-000007.md) | [99.9](/filings/0000080035-26-000017.md) | [114](/filings/0000080035-26-000030.md) | [125](/filings/0000080035-25-000022.md) | [121 d](/filings/0000080035-26-000007.md) | [121](/filings/0000080035-26-000017.md) | [140](/filings/0000080035-26-000030.md) |
| Gross profit | $m | [54.1](/filings/0001628280-24-044522.md) | [48.1 d](/filings/0000080035-26-000007.md) | [44.1](/filings/0001628280-25-021769.md) | [44.3](/filings/0000080035-25-000013.md) | [45.8](/filings/0000080035-25-000022.md) | [55.6 d](/filings/0000080035-26-000007.md) | [48.7](/filings/0000080035-26-000017.md) | [55.4](/filings/0000080035-26-000030.md) | [52.8](/filings/0000080035-25-000022.md) | [51.6 d](/filings/0000080035-26-000007.md) | [55.2](/filings/0000080035-26-000017.md) | [73.0](/filings/0000080035-26-000030.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [20.1](/filings/0001628280-24-044522.md) | [6.9 d](/filings/0000080035-26-000007.md) | [11.6](/filings/0001628280-25-021769.md) | [11.3](/filings/0000080035-25-000013.md) | [10.4](/filings/0000080035-25-000022.md) | [17.5 d](/filings/0000080035-26-000007.md) | [13.1](/filings/0000080035-26-000017.md) | [17.1](/filings/0000080035-26-000030.md) | [13.1](/filings/0000080035-25-000022.md) | [11.7 d](/filings/0000080035-26-000007.md) | [13.7](/filings/0000080035-26-000017.md) | [27.9](/filings/0000080035-26-000030.md) |
| Interest expense | $m | [1.0](/filings/0000950170-23-058114.md) | [0.7 d](/filings/0000950170-24-028605.md) | [0.7](/filings/0000950170-24-051969.md) | [0.6](/filings/0000950170-24-089123.md) | [0.6](/filings/0000080035-25-000022.md) | [0.4 d](/filings/0000080035-26-000007.md) | [0.4](/filings/0000080035-26-000017.md) | [0.3](/filings/0000080035-26-000030.md) | [0.3](/filings/0000080035-25-000022.md) | [0.3 d](/filings/0000080035-26-000007.md) | [0.2](/filings/0000080035-26-000017.md) | [0.2](/filings/0000080035-26-000030.md) |
| Income tax | $m | [4.4](/filings/0001628280-24-044522.md) | [0.7 d](/filings/0000080035-26-000007.md) | [2.3](/filings/0001628280-25-021769.md) | [1.8](/filings/0000080035-25-000013.md) | [2.7](/filings/0000080035-25-000022.md) | [6.9 d](/filings/0000080035-26-000007.md) | [2.1](/filings/0000080035-26-000017.md) | [4.6](/filings/0000080035-26-000030.md) | [(0.3)](/filings/0000080035-25-000022.md) | [3.9 d](/filings/0000080035-26-000007.md) | [3.8](/filings/0000080035-26-000017.md) | [6.9](/filings/0000080035-26-000030.md) |
| Net income | $m | [15.1](/filings/0001628280-24-044522.md) | [6.3 d](/filings/0000080035-26-000007.md) | [9.6](/filings/0001628280-25-021769.md) | [9.4](/filings/0000080035-25-000013.md) | [7.7](/filings/0000080035-25-000022.md) | [10.5 d](/filings/0000080035-26-000007.md) | [11.5](/filings/0000080035-26-000017.md) | [12.7](/filings/0000080035-26-000030.md) | [2.6](/filings/0000080035-25-000022.md) | [8.4 d](/filings/0000080035-26-000007.md) | [10.5](/filings/0000080035-26-000017.md) | [21.5](/filings/0000080035-26-000030.md) |
| Diluted EPS | $ per share | [3.03](/filings/0001628280-24-044522.md) | not reported | [1.94](/filings/0001628280-25-021769.md) | [1.89](/filings/0000080035-25-000013.md) | [1.54](/filings/0000080035-25-000022.md) | not reported | [2.33](/filings/0000080035-26-000017.md) | [2.56](/filings/0000080035-26-000030.md) | [0.53](/filings/0000080035-25-000022.md) | not reported | [2.14](/filings/0000080035-26-000017.md) | [4.49](/filings/0000080035-26-000030.md) |
| Basic EPS | $ per share | [3.08](/filings/0001628280-24-044522.md) | not reported | [1.95](/filings/0001628280-25-021769.md) | [1.91](/filings/0000080035-25-000013.md) | [1.57](/filings/0000080035-25-000022.md) | not reported | [2.34](/filings/0000080035-26-000017.md) | [2.58](/filings/0000080035-26-000030.md) | [0.53](/filings/0000080035-25-000022.md) | not reported | [2.15](/filings/0000080035-26-000017.md) | [4.51](/filings/0000080035-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [338](/filings/0000950170-23-058114.md) | [325](/filings/0001628280-25-012640.md) | [314](/filings/0000950170-24-051969.md) | [305](/filings/0000950170-24-089123.md) | [321](/filings/0001628280-24-044522.md) | [316](/filings/0000080035-26-000007.md) | [327](/filings/0001628280-25-021769.md) | [353](/filings/0000080035-25-000013.md) | [360](/filings/0000080035-25-000022.md) | [363](/filings/0000080035-26-000030.md) | [371](/filings/0000080035-26-000017.md) | [397](/filings/0000080035-26-000030.md) |
| Total assets | $m | [607](/filings/0000950170-23-058114.md) | [603](/filings/0001628280-25-012640.md) | [586](/filings/0000950170-24-051969.md) | [573](/filings/0000950170-24-089123.md) | [592](/filings/0001628280-24-044522.md) | [574](/filings/0000080035-26-000007.md) | [592](/filings/0001628280-25-021769.md) | [631](/filings/0000080035-25-000013.md) | [645](/filings/0000080035-25-000022.md) | [654](/filings/0000080035-26-000030.md) | [662](/filings/0000080035-26-000017.md) | [697](/filings/0000080035-26-000030.md) |
| Current liabilities | $m | [136](/filings/0000950170-23-058114.md) | [111](/filings/0001628280-25-012640.md) | [99.7](/filings/0000950170-24-051969.md) | [104](/filings/0000950170-24-089123.md) | [114](/filings/0001628280-24-044522.md) | [108](/filings/0000080035-26-000007.md) | [106](/filings/0001628280-25-021769.md) | [115](/filings/0000080035-25-000013.md) | [116](/filings/0000080035-25-000022.md) | [115](/filings/0000080035-26-000030.md) | [124](/filings/0000080035-26-000017.md) | [133](/filings/0000080035-26-000030.md) |
| Long-term debt | $m | [45.3](/filings/0000950170-23-058114.md) | [48.8](/filings/0001628280-25-012640.md) | [47.9](/filings/0000950170-24-051969.md) | [28.8](/filings/0000950170-24-089123.md) | [24.6](/filings/0001628280-24-044522.md) | [18.4](/filings/0000080035-26-000007.md) | [25.7](/filings/0001628280-25-021769.md) | [27.9](/filings/0000080035-25-000013.md) | [31.3](/filings/0000080035-25-000022.md) | [32.9](/filings/0000080035-26-000030.md) | [34.7](/filings/0000080035-26-000017.md) | [35.9](/filings/0000080035-26-000030.md) |
| Current portion of debt | $m | [6.7](/filings/0000950170-23-058114.md) | [6.5](/filings/0001628280-25-012640.md) | [7.1](/filings/0000950170-24-051969.md) | [2.8](/filings/0000950170-24-089123.md) | [2.6](/filings/0001628280-24-044522.md) | [2.4](/filings/0000080035-26-000007.md) | [3.4](/filings/0001628280-25-021769.md) | [3.9](/filings/0000080035-25-000013.md) | [4.7](/filings/0000080035-25-000022.md) | [5.4](/filings/0000080035-26-000030.md) | [5.9](/filings/0000080035-26-000017.md) | [5.1](/filings/0000080035-26-000030.md) |
| Short-term borrowings | $m | not reported | [13.5](/filings/0001628280-25-012640.md) | not reported | not reported | not reported | [10.2](/filings/0000080035-26-000007.md) | not reported | not reported | not reported | [6.6](/filings/0000080035-26-000007.md) | not reported | not reported |
| Shareholders' equity | $m | [400](/filings/0000950170-23-058114.md) | [416](/filings/0001628280-25-012640.md) | [413](/filings/0000950170-24-051969.md) | [416](/filings/0000950170-24-089123.md) | [429](/filings/0001628280-24-044522.md) | [422](/filings/0000080035-26-000007.md) | [436](/filings/0001628280-25-021769.md) | [461](/filings/0000080035-25-000013.md) | [466](/filings/0000080035-25-000022.md) | [476](/filings/0000080035-26-000030.md) | [474](/filings/0000080035-26-000017.md) | [495](/filings/0000080035-26-000030.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [42.5 d](/filings/0001628280-24-044522.md) | [19.3 d](/filings/0000080035-26-000007.md) | [5.8](/filings/0001628280-25-021769.md) | [28.3 d](/filings/0000080035-25-000013.md) | [9.4 d](/filings/0000080035-25-000022.md) | [24.1 d](/filings/0000080035-26-000007.md) | [5.7](/filings/0000080035-26-000017.md) | [26.9 d](/filings/0000080035-26-000030.md) | [18.9 d](/filings/0000080035-25-000022.md) | [21.9 d](/filings/0000080035-26-000007.md) | [6.0](/filings/0000080035-26-000017.md) | [25.2 d](/filings/0000080035-26-000030.md) |
| Capital expenditure | $m | [9.9 d](/filings/0001628280-24-044522.md) | [8.2 d](/filings/0000080035-26-000007.md) | [3.9](/filings/0001628280-25-021769.md) | [3.7 d](/filings/0000080035-25-000013.md) | [3.6 d](/filings/0000080035-25-000022.md) | [3.4 d](/filings/0000080035-26-000007.md) | [11.0](/filings/0000080035-26-000017.md) | [8.4 d](/filings/0000080035-26-000030.md) | [10.6 d](/filings/0000080035-25-000022.md) | [10.2 d](/filings/0000080035-26-000007.md) | [10.0](/filings/0000080035-26-000017.md) | [7.0 d](/filings/0000080035-26-000030.md) |
| Dividends paid | $m | [1.0 d](/filings/0001628280-24-044522.md) | [1.0 d](/filings/0000080035-26-000007.md) | [1.1](/filings/0001628280-25-021769.md) | [1.0 d](/filings/0000080035-25-000013.md) | [1.0 d](/filings/0000080035-25-000022.md) | [1.0 d](/filings/0000080035-26-000007.md) | [1.2](/filings/0000080035-26-000017.md) | [1.0 d](/filings/0000080035-26-000030.md) | [1.0 d](/filings/0000080035-25-000022.md) | [1.0 d](/filings/0000080035-26-000007.md) | [1.1](/filings/0000080035-26-000017.md) | [1.0 d](/filings/0000080035-26-000030.md) |
| Share repurchases | $m | [0.6 d](/filings/0001628280-24-044522.md) | [0.0 d](/filings/0000080035-26-000007.md) | [0.0](/filings/0001628280-25-021769.md) | [0.1 d](/filings/0000080035-25-000013.md) | [0.0 d](/filings/0000080035-25-000022.md) | [0.1 d](/filings/0000080035-26-000007.md) | [0.1](/filings/0000080035-26-000017.md) | [0.0 d](/filings/0000080035-26-000030.md) | [0.3 d](/filings/0000080035-25-000022.md) | [0.7 d](/filings/0000080035-26-000007.md) | [0.7](/filings/0000080035-26-000017.md) | [0.3 d](/filings/0000080035-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,036](/filings/0000950170-23-058114.md) | [4,997](/filings/0000950170-24-051969.md) | [5,024](/filings/0000950170-24-089123.md) | [4,990](/filings/0001628280-24-044522.md) | [4,944](/filings/0001628280-25-021769.md) | [4,964](/filings/0000080035-25-000013.md) | [4,977](/filings/0000080035-25-000022.md) | [4,950](/filings/0000080035-26-000017.md) | [4,955](/filings/0000080035-26-000030.md) | [4,941](/filings/0000080035-25-000022.md) | [4,927](/filings/0000080035-26-000017.md) | [4,794](/filings/0000080035-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,888,701 at 2026-07-17, from the cover of the [10-Q filed 2026-07-30](/filings/0000080035-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.